pre-seed
Stage
1
Investors
About
Belyntic develops novel immunotherapies and vaccines that leverage synthetic long peptides and AI-driven design to induce targeted T cell responses against infectious diseases and cancer.
Explore Belyntic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.